By: ICN Bureau
Last updated : February 02, 2026 2:59 pm
Nuclear import duty exemptions aligned with SHANTI Act reforms to boost potential investors
Union Minister of State (Independent Charge) for Science and Technology; Earth Sciences and Minister of State for PMO, Department of Atomic Energy, Department of Space, Personnel, Public Grievances and Pensions, Dr. Jitendra Singh said the Union Budget 2026–27 announcement of "Biopharma Shakti" will catalyse India's global role in the next industrial revolution and also India as a global biomanufacturing hub.
The Minister said that the announcement lays the groundwork for India’s participation in the next phase of the global industrial transition, with targeted measures in biopharma manufacturing, geospatial infrastructure, carbon capture and advanced energy technologies.
Welcoming the Budget, the Minister said the announcement of Biopharma Shakti, with a Rs. 10,000 crore outlay, marks a significant step in expanding India’s bio-economy beyond conventional pharmaceuticals into advanced biologics, biosimilars and medical devices.
He said the initiative covers both drugs and devices, with a strong emphasis on cost-effective, indigenously developed technologies, enabling India to move up the global value chain.
Singh said the budget measure builds on the work already underway under the National Biopharma Mission of the Department of Biotechnology, which has supported vaccine development, biologics, biosimilars and indigenous diagnostics through a network of clinical trial sites, manufacturing facilities, and technology transfer offices.
He noted that India has already emerged as a leading bio-economy player, ranking among the top ten global bio-economies and among the top three countries in the Asia-Pacific region, and said Biopharma Shakti would help consolidate this position by scaling up innovation and manufacturing simultaneously. The Minister added that the focus on efficient resource use and value addition also aligns the bio-pharma push with circular economy principles.
The Minister also referred to budget provisions aimed at strengthening the nuclear energy ecosystem, including customs duty exemptions on the import of components and equipment required for nuclear power plants.
Singh said the measure is aligned with SHANTI Act, which seek to widen the scope for private sector participation in the nuclear sector.
He said enabling investors and operators to access globally competitive equipment and technologies is essential for improving efficiency, accelerating capacity creation and encouraging credible private participation in nuclear power projects.
Turning to clean technologies, Singh highlighted the budget’s proposal of an outlay of Rs. 20,000 crore over five years for Carbon Capture, Utilisation and Storage (CCUS) technologies.
He said the funding would support the scale-up of carbon capture projects and improve technology readiness levels for wider industrial application.
The Minister pointed out that biotechnology-enabled carbon utilisation and conversion pathways are increasingly relevant as India seeks growth models that combine industrial expansion with environmental responsibility.
Singh said the budget’s science-linked measures reflect a shift towards coordinated, mission-oriented policymaking, where research, manufacturing and deployment move in tandem.
He added that the emphasis on biopharma, geospatial systems, clean energy and advanced infrastructure demonstrates India’s readiness to compete in technology-intensive sectors that are expected to shape global growth in the coming decades.